PuSH - Publikationsserver des Helmholtz Zentrums München

Activation of DNA damage response by antitumor therapy counteracts the activity of vinca alkaloids.

Anticancer Res. 33, 5273-5287 (2013)
Verlagsversion Zum Artikel PMC
Open Access Gold
Background/Aim: Anthracyclines have been proven able to reduce the activity of vinca alkaloids by induction of cell-cycle arrest. The present study aims at identifying the critical initiation steps of signal transduction which transduce the inhibitory effects on the cytotoxicity of vinca alkaloids. MATERIALS AND METHODS: Several new cytostatic drug classes were evaluated together with vincristine in tumor cell lines and patients' tumor cells. RNA interference was used for molecular analyses. RESULTS: Inhibition of vincristine was observed by all cytostatic drugs, which induced cell-cycle arrest. Knockdown of proteins of the DNA damage response ascribed the inhibitory effect to a common pathway involving Chk-1, p53 and p21. Upstream of Chk-1 signal transduction depended on both ATM and ATR for all drugs except methotrexate. CONCLUSION: We have identified critical signaling steps of the DNA damage response system activated by cytostatic drugs, which reduce the anti-tumor activity of vinca alkaloids. The obtained results encourage the development of novel therapeutic strategies to prevent pathway interactions based on the molecular understanding of drug action and drug-drug interactions.  
Impact Factor
Scopus SNIP
Altmetric
1.713
0.701
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter ATM; ATR; Chk1; DNA damage; cell-cycle arrest; p21; p53; vinca alkaloids; Cell-cycle Arrest; Cancer-therapy; Tumor-cells; P53; Checkpoints; Death; Anthracyclines; Proliferation; Mechanisms; Caspase-8
Sprache
Veröffentlichungsjahr 2013
HGF-Berichtsjahr 2013
ISSN (print) / ISBN 0250-7005
e-ISSN 1791-7530
Zeitschrift Anticancer Research
Quellenangaben Band: 33, Heft: 12, Seiten: 5273-5287 Artikelnummer: , Supplement: ,
Verlag International Institute of Anticancer Research
Begutachtungsstatus Peer reviewed
POF Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-501590-001
PubMed ID 24324060
Erfassungsdatum 2013-12-12